
Language
Institute for Strategic Biomedical Research

AMRIT-ON is a private international research platform. Based on more than 20 years of scientific work, we develop innovative biologically oriented approaches in oncology, gerontology, regenerative medicine, and cardiovascular diseases.
Preclinical stage and early clinical phases: successfully completed.
0 1
0 2
0 3
Current status: ongoing Phase III clinical evaluation. Protection & registration: international patent protection; officially registered oral nutraceutical form. Funding: independent and entirely private.
Our programs cover a broad spectrum of oncological diseases.

including brain, breast, lung, colorectal, pancreatic, and prostate cancers, as well as melanoma.

ovarian, cervical, and endometrial cancers.

lymphomas, leukemias, sarcomas, neuroendocrine tumors, and skin cancer.
We combine translational oncology with integrative approaches. Our work is based on: biologically active natural compounds; multicomponent regulatory mechanisms; strictly personalized models.

Although we do not promise a universal cure, the observations and research data accumulated to date demonstrate impressive results and good tolerability, generating significant scientific interest.



AMRIT-ON is not a mass-market product. We provide high-quality personalized biomedical solutions within individually adapted research programs under physician supervision.

Individual adaptation: the composition and configuration of the oral form are modified for each specific patient.
limited production
continuous medical supervision
strict confidentiality
due to the high complexity and intensive support involved, the programs belong to a high and ultra-premium pricing segment.

We are interested in cooperation with private clinics, oncology centers, and physicians for joint application and further research within our programs.
Authorized access includes clinical research data and private communication channel. Available exclusively under NDA.
Amrit-On is building an international system that brings together science, independent laboratories and clinical partners around each individual patient.

First — an individual laboratory assessment.Then — a decision.
When biopsy material is available, an individually selected composition can be studied on the patient's own biological material even before the program begins, with a laboratory assessment of its effectiveness and safety.
Where laboratory testing shows that the individually selected Amrit-On program demonstrates greater effectiveness compared with other tested therapy options, the patient, together with their treating physician, may decide to participate in the Institute's rehabilitation and recovery program.
From biological material to an individualized program
Biopsy
→Laboratory assessment and comparison
→Individualized composition
→Decision by physician and patient
→Personalized program
→Clinical support
Today the Amrit-On international network includes

laboratory capabilities for studying the patient's biological material

implementation and clinical support of rehabilitation and recovery programs

the possibility of organizing them anywhere in the world — in accordance with local legislation

when required, advanced diagnostics, surgery and subsequent recovery at a clinical partner
The geography of our partnership network continues to expand.
Amrit-On rehabilitation and recovery programs do not include chemotherapy or radiotherapy. The need for other treatment methods is determined by the patient together with their treating physician.
The AMRIT-ON technological and research platform is being developed on the basis of international medical and clinical cooperation. Licensed physicians, medical specialists, and clinical partners in Turkey and across Europe are involved in patient support and the implementation of individualized programs.

All individualized programs are conducted exclusively with the participation of qualified medical specialists and within the framework of professional medical supervision.

Clinical division
The AMRIT-ON clinical direction brings together inpatient facilities, physicians, research teams, and licensed medical organizations able to receive patients, supervise programs, and contribute to the development of the international network.

Inpatient facilities
Physician teams
Licenses and status
The partners section will present branded status layouts for clinics. Before a specific clinic name is published, the card may be shown as a partner clinic of the corresponding status.
AMRIT-ON Clinical Partner
Partner clinic of the corresponding status
The core international status. The clinic participates in the program, receives patients, and cooperates with the Institute within the clinical framework.
International Program
AMRIT-ON Clinical Partner
Partner clinic of the corresponding status
The next level for clinics that jointly develop the program and participate in research, training, exchange of expertise, and scientific work.
Research & Education
AMRIT-ON Clinical Partner
Partner clinic of the corresponding status
A prestigious status for the first organizations that joined before the broad international launch. Once the network is formed, this status is no longer issued.
Limited Founding Status
AMRIT-ON Clinical Partner
Partner clinic of the corresponding status
The highest level for clinics with confirmed results, extensive experience, and the role of an AMRIT-ON international reference center.
Reference Center
AMRIT-ON is open to strategic partnerships with investors and biotech structures interested in investing in promising and innovative developments in biomedicine and oncology.

Additional information regarding the technology's capabilities, scientific data, and potential application formats will be provided individually to interested partners after defining a joint cooperation roadmap and under NDA.